1. Home
  2. OMDA vs ODTX Comparison

OMDA vs ODTX Comparison

Compare OMDA & ODTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omada Health Inc.

OMDA

Omada Health Inc.

N/A

Current Price

$20.41

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$20.42

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OMDA
ODTX
Founded
2011
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
OMDA
ODTX
Price
$20.41
$20.42
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
$28.42
★ $35.75
AVG Volume (30 Days)
★ 936.3K
245.6K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.27
N/A
EPS
★ 0.04
N/A
Revenue
★ $260,210,000.00
N/A
Revenue This Year
$30.15
N/A
Revenue Next Year
$20.42
N/A
P/E Ratio
$489.50
★ N/A
Revenue Growth
★ 53.24
N/A
52 Week Low
$10.28
$15.10
52 Week High
$26.92
$29.05

Technical Indicators

Market Signals
Indicator
OMDA
ODTX
Relative Strength Index (RSI) 48.43 48.10
Support Level $19.31 $22.30
Resistance Level $21.52 $28.53
Average True Range (ATR) 0.85 1.99
MACD 0.06 -0.22
Stochastic Oscillator 74.17 50.43

Price Performance

Historical Comparison
OMDA
ODTX

About OMDA Omada Health Inc.

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

Share on Social Networks: